Skip Navigation or Skip to Content
Blog Author
Tenthpin

California’s Low-Cost Insulin Is Symptom Of Lifesaving Innovations To Come

Featured image: California’s Low-Cost Insulin Is Symptom Of Lifesaving Innovations To Come

Susan Galer has published on Forbes covering the SAP Life Sciences event, featuring remarks from Michael Schmidt’s excellent trends session.

Read the full article here

screenshot_2022-07-25_at_11.52.3

screenshot_2022-07-25_at_11.53.0

screenshot_2022-07-25_at_11.53.2

screenshot_2022-07-25_at_11.53.4

screenshot_2022-07-25_at_11.54.1

Share This Blog

Related insights

Innovation is critical, but it’s also complex. In the highly regulated, data-intensive world of Life Sciences, success requires...

Pharmaceutical development is undergoing significant transformational changes. The prime candidate for modernization in clinical...

The shift to patient centricity, AI, and digital ecosystems is disrupting the Life Sciences industry. What was once a...

We are a globally leading business and technology boutique consultancy for the Life Sciences industry. Our clients are leading companies from pharma, biotech, med tech, healthcare & animal health.

© 2025 Tenthpin AG | Illustrations by: www.till-lauer.ch